Could Genomics Influence Prostate Cancer Treatment?
Prostate cancer is one of the most common cancers diagnosed in the United States. About one-third of men diagnosed...
Category: Journals
Prostate cancer is one of the most common cancers diagnosed in the United States. About one-third of men diagnosed...
Several clinical trials are underway in which PARP inhibitors are being tested in breast cancers, mostly triple-negative breast cancers,...
In recent years, the U.S. Food and Drug Administration has approved immune checkpoint inhibitors, a class of immunotherapy, to...
A pair of studies published recently in journals of the American Association for Cancer Research bring to our attention...
Earlier this year, a study published in Cancer Discovery, a journal of the American Association for Cancer Research (AACR),...
A major objective of former Vice President Joe Biden’s National Cancer Moonshot Initiative is breaking down silos and sharing...
As we learned recently, Senator John McCain was diagnosed with glioblastoma multiforme, an aggressive form of central nervous system...
Yesterday, the American Association for Cancer Research (AACR) joined the American Cancer Society (ACS), the American Society of Clinical...
recent data suggest that there is another potential contender for a biomarker-based FDA approval: a targeted therapeutic called larotrectinib...
There is perhaps nothing more painful for parents than receiving a cancer diagnosis for their child. Childhood cancers are...